Carlo Unverzagt

Title: Carlo Unverzagt: Innovator in Immunology and Cell Adhesion Inhibition

Introduction

Carlo Unverzagt is a notable inventor based in Munich, Germany. He has made significant contributions to the fields of immunology and cell adhesion through his innovative patents. With a total of 2 patents, Unverzagt's work has the potential to impact medical diagnostics and therapeutic approaches.

Latest Patents

Unverzagt's latest patents include an immunological process for prostate-specific antigen (PSA) determination. This invention focuses on accurately determining free PSA, total PSA concentration, and PSA-serpin complexes. The process involves the addition of a nucleophile containing amine to the sample before determining the total PSA concentration. Additionally, he has developed anti-inflammatory cell adhesion inhibitors, which are compounds that can inhibit increased cell-cell adhesion. These compounds are useful in treating diseases associated with heightened cell adhesion and are incorporated into pharmaceutical compositions.

Career Highlights

Throughout his career, Carlo Unverzagt has worked with prominent companies such as Glycorex AB and Roche Diagnostics GmbH. His experience in these organizations has allowed him to refine his expertise in immunology and drug development.

Collaborations

Unverzagt has collaborated with notable colleagues, including Gregor Kuznik and Gerhard Kretzschmar. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Carlo Unverzagt's contributions to immunology and cell adhesion inhibition highlight his role as a significant inventor in the medical field. His innovative patents demonstrate the potential for improved diagnostic and therapeutic solutions.